Clinical Trial Update: ACT with NMOSD Patients and Caregivers Pilot Study [NA]

View source ↗

Summary

A completed pilot clinical trial evaluating ACT with Neuromyelitis Optica Spectrum Disorder patients and caregivers; sponsored by Thomas Jefferson University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Snippet

Sponsor: Thomas Jefferson University | Conditions: NMO Spectrum Disorder | NA | Status: COMPLETED